Edward G. Carr's Insider Trades & SAST Disclosures

Edward G. Carr's most recent trade in Dianthus Therapeutics Inc was a trade of 60,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 3, 2025.

Share

Note

This is a custom search result for pattern Edward G. Carr.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Dianthus Therapeutics Inc 10-year high	Edward G. Carr	CHIEF ACCOUNTING OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Feb 2025	60,000	60,000	-		-	Stock Option (Right to Buy)
Dianthus Therapeutics Inc 10-year high	Edward G. Carr	CHIEF ACCOUNTING OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 May 2024	60,000	60,000	-		-	Stock Option (Right to Buy)
Dianthus Therapeutics Inc 10-year high	Edward G. Carr	CHIEF ACCOUNTING OFFICER	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Jan 2024	80,000	80,000	-		-	Stock Option (Right to Buy)
Abeona Therapeutics Inc	Edward G. Carr	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Aug 2021	476,000	476,000	-		-	Stock Option (right to buy)
Abeona Therapeutics Inc	Edward G. Carr	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Aug 2021	238,000	429,291 (0%)	0%		0	Common stock
Abeona Therapeutics Inc	Edward G. Carr	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 1.80 per share.	31 Mar 2021	35,000	191,291 (0%)	0%	1.8	62,846	Common stock
Abeona Therapeutics Inc	Edward G. Carr	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 1.85 per share.	31 Mar 2021	20,445	226,291 (0%)	0%	1.9	37,866	Common stock
Abeona Therapeutics Inc	Edward G. Carr	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2021	100,000	100,000	-		-	Stock Option (right to buy)
Abeona Therapeutics Inc	Edward G. Carr	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2021	50,000	246,736 (0%)	0%		0	Common stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades